Hideto Kawaratani

Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake

Kosuke Kaji, Norihisa Nishimura, Kenichiro Seki et al. · International Journal of Cancer · 2017 · 242 citations

Gut Dysbiosis Associated With Hepatitis C Virus Infection

Takako Inoue, Jiro Nakayama, Kei Moriya et al. · Clinical Infectious Diseases · 2018 · 183 citations · Full text

Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats

Kosuke Kaji, Hitoshi Yoshiji, Yasuhide Ikenaka et al. · Journal of Gastroenterology · 2013 · 130 citations

Liver Fibrosis, Pathology, Hepatic Fibrosis +16

Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity

Kosuke Kaji, Hiroaki Takaya, Soichiro Saikawa et al. · World Journal of Gastroenterology · 2017 · 99 citations · Full text

Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma

Hitoshi Yoshiji, Ryuichi Noguchi, Masahisa Toyohara et al. · Journal of Hepatology · 2009 · 88 citations

Oncology, Hepatology, Hepatocellular Carcinoma +10